FitLife Q3 revenue $23.5M (+47% YoY), net income $0.9M (-57%) on acquisition costs

FITLIFE BRANDS, INC.

2025-Q3 EPS reported $0.47 vs consensus $0.28 ▲ beat (+70.7%)

Revenue $23.5M, up 47% YoY; Irwin Naturals contributed $6.8M of the $7.5M increase.
Net income $0.9M ($0.10 basic EPS) vs $2.1M ($0.23) in Q3 2024, due to Irwin transaction costs and lower gross margin.
Adjusted EBITDA $3.8M, up 6% YoY; gross margin 37.2% vs 43.8% (38.9% ex inventory step-up).
Wholesale revenue +156% to $13.2M; online -5% to $10.3M with MRC traffic decline cited.
MusclePharm wholesale +112%; MRC challenged; CEO notes rising whey protein costs and consumer weakness.

item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001437749-25-034610
form_type: 8-K
ticker: FTLF
cik: 0001374328
company_name: FITLIFE BRANDS, INC.
filed_at: 2025-11-13T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.250435+00:00
generated_at: 2026-05-16T20:13:03.091557+00:00
sec_items: ["2.02", "7.01", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001437749-25-034610
json_url: https://secwatch.observer/filing/0001437749-25-034610.json
markdown_url: https://secwatch.observer/filing/0001437749-25-034610.md
text_url: https://secwatch.observer/filing/0001437749-25-034610.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1374328/000143774925034610/0001437749-25-034610-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1374328/000143774925034610/ftlf20251113_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001437749-25-034610

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.